PRESS RELEASE published on 03/11/2026 at 16:41, 4 months 29 days ago EQS-Adhoc: Knaus Tabbert AG publishes selected preliminary financial figures for the 2025 financial year Knaus Tabbert AG releases preliminary financial figures for 2025, reporting EUR 1.002 billion revenue and 2.7% adjusted EBITDA margin. Final audited results to be published on 31 March 2026 Revenue EBITDA Margin Financial Figures Knaus Tabbert AG 2025
BRIEF published on 12/23/2025 at 16:36, 7 months 17 days ago Knaus Tabbert AG risque une amende de 6,42 millions d'euros Knaus Tabbert Procédures Judiciaires Bien Spécifications De Poids Impact Financier De 2025
BRIEF published on 12/23/2025 at 16:36, 7 months 17 days ago Knaus Tabbert AG Faces EUR 6.42 Million Fine Fine Knaus Tabbert Legal Proceedings 2025 Financial Impact Weight Specifications
PRESS RELEASE published on 12/23/2025 at 16:31, 7 months 17 days ago EQS-Adhoc: Knaus Tabbert AG accepts fine for incorrect weight specifications Knaus Tabbert AG accepts fine of ca. EUR 6.42 million for incorrect weight specifications imposed by Stuttgart public prosecutor's office Knaus Tabbert AG Fine EU Regulation 596/2014 Incorrect Weight Specifications Stuttgart Public Prosecutor
BRIEF published on 12/01/2025 at 15:53, 8 months 8 days ago First Berlin Equity Research Discontinues Coverage of Planethic Group AG Analyst Recommendation Stock Rating First Berlin Research Coverage Planethic Group
BRIEF published on 12/01/2025 at 15:53, 8 months 8 days ago First Berlin Equity Research cesse de suivre Planethic Group AG Premier Berlin Évaluation Des Actions Recommandation De L'analyste Couverture De La Recherche Groupe Planétaire
PRESS RELEASE published on 12/01/2025 at 15:48, 8 months 8 days ago Original-Research: Planethic Group AG (von First Berlin Equity Research GmbH): Not Rated First Berlin Equity Research discontinues coverage of Planethic Group AG, withdrawing recommendations and price targets. Analyst Ellis Acklin's insights are no longer available First Berlin Equity Research Ellis Acklin Coverage Discontinuation Planethic Group AG
BRIEF published on 11/13/2025 at 14:53, 8 months 26 days ago Knaus Tabbert AG Maintains 'Buy' Rating Despite Challenges First Berlin Equity Research BUY Rating Q3 Results Knaus Tabbert AG Chassis Bottleneck
BRIEF published on 11/13/2025 at 14:53, 8 months 26 days ago Knaus Tabbert AG maintient sa recommandation d'achat malgré les difficultés Knaus Tabbert AG Résultats Du Troisième Trimestre Évaluation D'achat Recherche Sur Les Actions De First Berlin Goulot D'étranglement Du Châssis
PRESS RELEASE published on 11/13/2025 at 14:48, 8 months 26 days ago Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen First Berlin Equity Research updates Buy rating for Knaus Tabbert AG with target price of €24, noting Q3 results and production challenges First Berlin Equity Research BUY Rating Q3 Results Knaus Tabbert AG EUR 24 Target Price
Published on 08/07/2026 at 23:15, 2 days 8 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 8 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 9 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 9 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 07:30, 28 minutes ago GEA second quarter figures: Double-digit growth in order intake and revenue, with significantly higher profitability
Published on 08/10/2026 at 07:29, 28 minutes ago EQS-Adhoc: q.beyond accelerates AI transformation and adjusts outlook for 2026 financial year
Published on 08/10/2026 at 07:10, 48 minutes ago Hypoport delivers solid gross profit growth and marked EBIT increase in first half of 2026
Published on 08/10/2026 at 07:00, 58 minutes ago Infracore SA announces partial exercise of the over-allotment option
Published on 08/10/2026 at 07:00, 58 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 58 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Published on 08/07/2026 at 18:54, 2 days 13 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 13 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 13 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
